手术治疗桡骨远端骨折的病例系列：植入物成本及其对患者预后的影响。
A Case Series of Surgically Treated Distal Radius Fractures: Implant Costs and Their Effect on Patient Outcomes.
机构信息
From the Department of Orthopaedic Surgery (Dr. Doxey, Mr. Huyke-Hernández, Dr. Cunningham), Park Nicollet Methodist Hospital, St. Louis Park, MN (Dr. Doxey, Huyke-Hernández, and Dr. Cunningham); the Department of Orthopaedic Surgery(Dr. Doxey, Huyke-Hernández, Dr. Robb, Dr. Bohn, Dr. Cunningham), TRIA Orthopaedic Institute, Bloomington, MN (Dr. Doxey, Huyke-Hernández, Dr. Robb, Dr. Bohn, and Dr. Cunningham); and the Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN (Dr. Bohn).
出版信息
J Am Acad Orthop Surg Glob Res Rev. 2023 Jul 7;7(7). doi: 10.5435/JAAOSGlobal-D-23-00026. eCollection 2023 Jul 1.
INTRODUCTION
Distal radius fractures (DRFs) are common injuries, warranting a need to analyze the cost of treatment. The purpose of this study was to analyze the effect of implant costs on patient-reported outcomes in DRFs.
METHODS
A PRO registry was retrospectively reviewed for isolated, surgically treated DRF patients. A total of 140 patients met criteria to be included in this study. Implant cost was obtained from the chargemaster database.
RESULTS
The average total implant cost was $1,289.67 ± 215.32. The average Patient-rated Wrist Evaluation scores preoperatively, at 6 weeks, and at 12 weeks were 70.8 ± 20.1, 36.6 ± 21.1, and 22.8 ± 18.0, respectively. No statistically significant relationships were observed between cost and Patient-rated Wrist Evaluation scores at 6 weeks or 12 weeks (r = -0.05, P = 0.59; r = -0.04, P = 0.64, respectively). Implant costs were shown to not be affected by fracture complexity (AO/OTA classification: 23A = $1,335.50, 23B = $1,246.86, and 23C = $1,293.14).
DISCUSSION
The total cost of implants did not influence patient outcomes indicating that patients receive no additional benefit from more costly constructs.
简介
桡骨远端骨折（DRF）较为常见，需要对其治疗成本进行分析。本研究旨在分析内植物成本对 DRF 患者报告结局的影响。
方法
对单纯手术治疗的桡骨远端骨折患者进行 PRO 注册回顾性研究。共有 140 例患者符合纳入本研究的标准。从费用主文件中获得植入物成本。
结果
平均总植入物成本为 1289.67 美元±215.32 美元。术前、6 周和 12 周的患者腕关节评估评分（Patient-rated Wrist Evaluation scores）分别为 70.8 ±20.1、36.6 ±21.1 和 22.8 ±18.0。在 6 周和 12 周时，成本与患者腕关节评估评分之间未观察到统计学显著相关性（r = -0.05，P = 0.59；r = -0.04，P = 0.64）。植入物成本与骨折复杂性（AO/OTA 分类：23A = 1335.50 美元，23B = 1246.86 美元，23C = 1293.14 美元）无关。
讨论
植入物总成本并未影响患者结局，这表明更昂贵的内植物并不能为患者带来额外益处。
Zotero 插件